# Opus Genetics, Inc.: Form 10-Q for the period ended Jun 30, 2017

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 10-Q
- Filed: 2017-08-04
- Accepted by EDGAR: Aug 4, 2017, 16:16 ET
- Period: 2017-06-30
- Accession: 0001140361-17-030254
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036117030254/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036117030254/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2017-04-01 to 2017-06-30 | $2.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2017-01-01 to 2017-06-30 | $4.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2017-04-01 to 2017-06-30 | −$4.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2017-01-01 to 2017-06-30 | −$8.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2017-04-01 to 2017-06-30 | $947.1k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2017-01-01 to 2017-06-30 | −$20.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-04-01 to 2017-06-30 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2017-01-01 to 2017-06-30 | −$0.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-04-01 to 2017-06-30 | $0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2017-01-01 to 2017-06-30 | −$0.83 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-04-01 to 2017-06-30 | 28,265,440 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2017-01-01 to 2017-06-30 | 24,932,705 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Cash and equivalents | at 2017-06-30 | $8.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-06-30 | $28.0m | us-gaap:AssetsCurrent |
| Total assets | at 2017-06-30 | $28.1m | us-gaap:Assets |
| Total liabilities | at 2017-06-30 | $12.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-06-30 | $15.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036117030254/form10q.htm

Filed Aug 4, 2017.
Source: SEC EDGAR, the filing index for accession 0001140361-17-030254. Last ingested by Listed: Nov 12, 2026, 19:22 ET. No prices; not investment advice.
